CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+39.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.6B
AUM Growth
+$2.03B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
884
New
Increased
Reduced
Closed

Top Buys

1
+$146M
2
+$65.4M
3
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Top Sells

1
+$76.3M
2
+$35.6M
3
+$31.7M
4
BNTX icon
BioNTech
BNTX
+$25.5M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$25.1M

Sector Composition

1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
826
– –
-202,595
827
– –
-2,189
828
– –
-2,265
829
– –
-170,000
830
– –
-352,760
831
– –
-350,925
832
– –
-486,864
833
– –
-50
834
– –
-1,400
835
– –
-8,171
836
– –
-346,601
837
– –
-16,616
838
– –
-274,689
839
– –
-2,406,686
840
– –
-155,972
841
– –
-297,448
842
– –
-1,047,755
843
– –
-106,369
844
– –
-262,804
845
– –
-244,395
846
– –
-840,936
847
– –
-460,929
848
– –
-196,829
849
– –
-219,575
850
– –
-29,434
31 32 33
34
35